Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

68° Partly Cloudy

Site search

Home
News
- Local News
Sports
Obituaries
e-Edition
Classifieds
Explore the Sheyenne
Archives
Best of 2026

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Aura Biosciences, Inc. - Common Stock (NQ:AURA)

6.075 -0.205 (-3.26%)

Delayed Quote Updated: 12:03 PM EDT, Oct 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aura Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Aura Biosciences Reports First Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights

May 12, 2022

From Aura Biosciences Inc.

Via Business Wire

Aura Biosciences Presents Preclinical Data Highlighting AU-011’s Anti-Tumor Activity in Choroidal Metastasis, an Additional Ocular Oncology Indication at the 2022 ARVO Annual Meeting

May 03, 2022

From Aura Biosciences Inc.

Via Business Wire

Aura Biosciences to Present at the 2022 Bank of America Healthcare Conference

May 03, 2022

From Aura Biosciences Inc.

Via Business Wire

Aura Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical Development and Operational Highlights

March 23, 2022

From Aura Biosciences Inc.

Via Business Wire

Aura Biosciences Announces Orphan Drug Designation Granted to AU-011 by European Commission for the Treatment of Uveal Melanoma (Includes Choroidal Melanoma)

March 21, 2022

From Aura Biosciences Inc.

Via Business Wire

Aura Biosciences to Host Virtual Investor Day Focused on Ocular Oncology with Key Thought Leaders on March 22

March 15, 2022

From Aura Biosciences Inc.

Via Business Wire

Aura Biosciences to Participate at the 42nd Annual Cowen Virtual Health Care Conference

February 28, 2022

From Aura Biosciences Inc.

Via Business Wire

Aura Biosciences to Present Preclinical Data Demonstrating Applicability of AU-011 in Bladder Cancer at the 2022 ASCO Genitourinary Cancer Symposium

February 14, 2022

From Aura Biosciences Inc.

Via Business Wire

Aura Biosciences to Participate at the 11th Annual SVB Leerink Global Healthcare Conference

February 09, 2022

From Aura Biosciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 29, 2021

Gainers Krystal Biotech (NASDAQ:KRYS) shares moved upwards by 118.21% to $86.87 during Monday's regular session. Krystal Biotech's stock is trading at a volume of...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 24, 2021

Gainers iSpecimen (NASDAQ:ISPC) shares in...

Via Benzinga

52 Biggest Movers From Yesterday ↗

January 20, 2022

Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it will be acquired by UCB for approximately $1.9 billion. G...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 24, 2021

Gainers Biofrontera (NASDAQ:BFRI) shares ...

Via Benzinga

Aura Biosciences to Participate at the 4th Annual Evercore ISI HealthCONx Conference

November 23, 2021

From Aura Biosciences, Inc.

Via Business Wire

50 Biggest Movers From Yesterday ↗

November 30, 2021

Gainers Krystal Biotech, Inc. (NASDAQ: KRYS) shares surged 121.7% to close at $88.24 on Monday after the company announced positive topline results from the GEM-3 Phase 3 trial...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 22, 2021

Gainers iSpecimen (NASDAQ:ISPC) stock moved upwards by 95.32% to $9.61 during Monday's regular session. Trading volume for iSpecimen's stock is 70.9 million as of...

Via Benzinga

The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week ↗

November 21, 2021

Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 23, 2021 ↗

November 23, 2021

Upgrades Keefe, Bruyette & Woods upgraded the previous rating for CBRE Group Inc (NYSE:

Via Benzinga

80 Biggest Movers From Yesterday ↗

November 17, 2021

Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares surged 55% to close at $1.00 on Tuesday as the company reported a narrower Q3 loss. Progenity, Inc. (NASDAQ: PROG)...

Via Benzinga

70 Biggest Movers From Yesterday ↗

November 16, 2021

Gainers Casper Sleep Inc. (NYSE: CSPR) shares jumped 88.5% to close at $6.69 on Monday after the company agreed to be acquired by Durational Capital Management. The...

Via Benzinga

Aura Biosciences Presents Final Phase 1b/2 Data for its first Virus-Like Drug Conjugate, AU-011, in Patients with Choroidal Melanoma at the American Academy of Ophthalmology 2021 Annual Meeting

November 15, 2021

From Aura Biosciences

Via Business Wire

64 Biggest Movers From Yesterday ↗

November 09, 2021

Gainers Pioneer Power Solutions, Inc. (NASDAQ: PPSI) shares jumped 219% to close at $10.40 on Monday after the company announced the launch of its E-Boost portfolio of mobile...

Via Benzinga

4 Stocks Insiders Are Buying ↗

November 05, 2021

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 03, 2021

Good morning, trader! We're starting the day off right with a dive into the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

25 Stocks Moving in Wednesday's Pre-Market Session ↗

November 03, 2021

Gainers Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 56.4% to $26.20 in pre-market trading on the heels of three new announcements from the company outlining strategic plans to...

Via Benzinga

Aura Biosciences Announces Pricing of Initial Public Offering

October 28, 2021

From Aura Biosciences, Inc.

Via Business Wire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Entertainment
Local Events
Sports
Obituaries
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

times-online.com
146 Third St. N.E.
Valley City, ND 58072
Phone: 701-845-0463
Email: editor@times-online.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Aura Biosciences, Inc. - Common Stock (NQ:AURA)

All News about Aura Biosciences, Inc. - Common Stock

Sections

Services

Follow Us